REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/23/2025
Back to search
Official data from USPTO
CAPRICORN PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CAPRICORN PHARMA
ST13
US500000086672940Class
5
Filing
86672940
Registration
5025110
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
08/24/2025
Trademark type
Word
Nice classes
5
Filing date
06/24/2015
Registration date
08/23/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/24/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/25/2015
First use in commerce
11/25/2015
Drawing code
4
Owner type
03
Owner location
Hyderabad 500 037, IN
Examiner
BAL,KAMAL SINGH
Law office
M70
Current location
TMO LAW OFFICE 116
Holders and representatives
Holders
D. M. (pessoa física)
Representatives
David W. OSborne Thorpe North & Western, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesic and muscle relaxant pharmaceutical preparations; Cardiovascular pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparationsappetite suppressants; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticalsanti-infectives; Pharmaceuticalslipid lowering agents
Publications
History of USPTO decisions and trademark events.
36 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/22/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/22/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/22/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/22/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/23/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/05/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2016
PUBO
PUBLISHED FOR OPPOSITION
06/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/04/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/28/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/27/2016
IUAA
USE AMENDMENT ACCEPTED
04/27/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2016
ALIE
ASSIGNED TO LIE
03/29/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/31/2015
GNRT
NON-FINAL ACTION E-MAILED
12/31/2015
CNRT
NON-FINAL ACTION WRITTEN
12/31/2015
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/09/2015
IUAF
USE AMENDMENT FILED
12/09/2015
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/08/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2015
GNRT
NON-FINAL ACTION E-MAILED
10/07/2015
CNRT
NON-FINAL ACTION WRITTEN
10/07/2015
DOCK
ASSIGNED TO EXAMINER
09/30/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2015
NWAP
NEW APPLICATION ENTERED
06/27/2015
Continuous trademark protection
Get notified about every new filing that threatens CAPRICORN PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.